P3 Health Partners (PIII) Stock Price, News & Analysis

Company Overview

P3 Health Partners Inc. (NASDAQ: PIII) is a physician-led, technology-enabled health care company focused on value-based care for Medicare Advantage beneficiaries. The company works with physicians, health plans and patients to coordinate care, improve health outcomes and manage health care services across the patient’s care journey.

P3 Health Partners supports its provider network with clinical programs, care coordination, data and analytics, population health management, and other administrative and operational services. Its model emphasizes primary care, preventive services, management of chronic conditions and collaboration among physicians, specialists and care teams.

Founded by physicians in 2017, P3 Health Partners became a publicly traded company through a business combination with Foresight Acquisition Corp. in 2021. The company has developed operations primarily in Nevada and Arizona and has been led by co-founder and Chief Executive Officer Dr. Sherif Abdou.

Key Stats

• Today's Range: $7.05 to $7.26
• 50-Day Range: $7.05 to $12.83
• 52-Week Range: $1.52 to $16.89
• Volume: 13,289 shs
• Average Volume: 19,611 shs
• Market Capitalization: $51.18 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $17.00
• Consensus Rating: Hold

P3 Health Partners Stock Analysis - MarketRank™

P3 Health Partners scored higher than 34% of companies evaluated by MarketBeat, and ranked 438th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

P3 Health Partners has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 1 sell rating.

Upside Potential

P3 Health Partners has a consensus price target of $17.00, representing about 141.1% upside from its current price of $7.05.

Amount of Analyst Coverage

P3 Health Partners has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of P3 Health Partners is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of P3 Health Partners is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.42% of the float of P3 Health Partners has been sold short.

Short Interest Ratio / Days to Cover

P3 Health Partners has a short interest ratio ("days to cover") of 1.19, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in P3 Health Partners has recently increased by 5.45%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

P3 Health Partners does not currently pay a dividend.

Dividend Growth

P3 Health Partners does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for P3 Health Partners this week, compared to 1 article on an average week.

Company Ownership

• Score: 1.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, P3 Health Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $824,000.00 in company stock.

Percentage Held by Insiders

10.86% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

7.75% of the stock of P3 Health Partners is held by institutions.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 9/24/2026
• Next Earnings (Estimated): 11/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:PIII
• CIK: 1832511
• Web: www.p3hp.org
• Phone: (312) 822-8897
• Fax: N/A
• Employees: 320
• Year Founded: N/A

Price Target and Rating

• Average Price Target for P3 Health Partners: $17.00
• High Price Target: $23.00
• Low Price Target: $14.00
• Potential Upside/Downside: +141.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($33.00)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$147.95 million
• Net Margins: -6.55%
• Pretax Margin: -15.12%
• Return on Equity: N/A
• Return on Assets: -16.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.46
• Quick Ratio: 0.46

Sales & Book Value

• Annual Sales: $1.46 billion
• Price / Sales: 0.04
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($21.55) per share
• Price / Book: -0.33

Miscellaneous

• Outstanding Shares: 7,260,000
• Free Float: 6,472,000
• Market Cap: $51.18 million
• Optionable: Not Optionable
• Beta: 1.63